Allergan Drug Buyers' Renewed Bid For Cert. Deemed 'Futile'
By Anne Cullen · April 12, 2019, 7:21 PM EDT
Purchasers of Allergan's ulcerative colitis drug won't get a second crack at class certification in their antitrust suit, as a Massachusetts federal judge has found their renewed effort would likely look...
To view the full article, register now.